|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| Company Information | 1 | 1 |
| Janssen-Cilag S.p.A. [NonUS -- Symbol : Private] | 1 | 1 |
| Formation Date: 1886 | 1 | 1 |
| Business Summary | 1 | 1 |
| Product Glance | 3 | 1 |
| Diseasehub Classification | 3 | 1 |
| Product Summary | 4 | 1 |
| Condition Treated | 4 | 3 |
| Partner | 6 | 1 |
| Product Details | 6 | 1 |
| 1. Arestal Description | 6 | 1 |
| Therapeutic Current Trial Trial Details Last Updated 2. Invega Description | 6 | 1 |
| Therapeutic Current Trial Trial Details | 6 | 5 |
| Last Updated 3. Dacogen Description | 8 | 1 |
| Last Updated Partnering Details | 11 | 1 |
| 4. Acnidazil Description | 11 | 1 |
| Therapeutic | 11 | 1 |
| Drug Class Current Trial Trial Details Last Updated 5. Daktacort Description | 12 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 6. Evra Description | 12 | 1 |
| Therapeutic Drug Class Current Trial M Trial Details Last Updated 7. Gyno-pevaryl Description | 12 | 1 |
| Therapeutic Drug Class Current Trial M Trial Details Last Updated 8. Micro-novum Description | 12 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 9. Nizcreme Description | 12 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 10. Ortho-est Description | 13 | 1 |
| Therapeutic Current Trial Trial Details Last Updated 11. Pevisone Description | 13 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 12. Prefesta Description | 13 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 13. Prepulsid Description | 13 | 1 |
| Therapeutic Current Trial Trial Details Last Updated 14. Retin-A Description | 13 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 15. Stugeron Description | 14 | 1 |
| Therapeutic Current Trial Trial Details Last Updated 17. Tramacet Description | 14 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 18. Tramal Description | 14 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 19. Tricilest Description | 14 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 20. Trinovum Description | 15 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 21. Eprex Description | 15 | 1 |
| Therapeutic Drug Class Current Trial Trial Details | 15 | 1 |
| Last Updated Partnering Details | 16 | 1 |
| 22. Hypnomidate Description | 16 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 23. Sublimaze Description | 16 | 1 |
| Therapeutic Drug Class Current Trial M Trial Details Last Updated 24. Evorel Conti Description | 16 | 1 |
| Therapeutic Drug Class Current Trial M Trial Details Last Updated 25. Evorel Sequi Description | 16 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 26. Velcade Description | 16 | 1 |
| Therapeutic Current Trial Trial Details | 17 | 3 |
| Last Updated Partnering Details | 18 | 1 |
| 27. Dipiperon (pipamperon) Central Nervous Description Dipiperon | 18 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 28. Ergamisol Description | 18 | 1 |
| Last Updated 29. Imap Disease Hub Description | 18 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 30. Impromen Description | 19 | 1 |
| Therapeutic Urinary Drug Class Urinary Current Trial M Trial Details Last Updated 33. Orap (pimozide) Central Description O | 19 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 34. Pariet Description | 19 | 1 |
| Last Updated 35. Pevaryl Description | 20 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 37. Rapifen Description | 20 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 39. Sibelium Description | 20 | 1 |
| Therapeutic Current Trial Trial Details Last Updated | 20 | 1 |
| 40. Sufenta (sufentanil) Central Description Sufenta | 21 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 41. Systen Description | 21 | 1 |
| Therapeutic Hormone Current Trial M Trial Details Presently Last Updated 5/8/2008 42. Tinset (oxatomide) Description Tinset | 21 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 44. Cilest Description | 21 | 1 |
| Therapeutic Current Trial Trial Details Last Updated 45. Reasec Description | 21 | 1 |
| Therapeutic | 21 | 1 |
| Drug Class Current Trial Trial Details Last Updated 46. Concerta Description | 22 | 1 |
| Therapeutic Drug Class Current Trial Trial Details | 22 | 2 |
| Last Updated Partnering Details 47. Gyno-Daktarin Description | 22 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 48. Durogesic Description | 22 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 49. Haldol Description | 23 | 1 |
| Therapeutic Current Trial Trial Details Last Updated 50. Imodium Description | 23 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 51. Leustatin Description | 23 | 1 |
| Therapeutic Current Trial Trial Details Last Updated 53. Motilium Description | 23 | 1 |
| Last Updated 54. Nizoral Description | 24 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated 55. Pancrease Description | 24 | 1 |
| Therapeutic Current Trial Trial Details Last Updated 56. Regranex Description | 24 | 1 |
| Therapeutic Current Trial Trial Details Last Updated 57. Reminyl Description | 24 | 1 |
| Therapeutic Current Trial Trial Details | 24 | 1 |
| Last Updated 59. Risperdal Description | 25 | 1 |
| Therapeutic Drug Class Current Trial Trial Details | 25 | 3 |
| Last Updated 4/28/2008 60. Sporanox (itraconazole) Infections Description Sporanox | 25 | 1 |
| Last Updated 11/21/2007 61. Topamax (topiramate) Central Description Topamax | 26 | 1 |
| Therapeutic Drug Class Current Trial Trial Details Last Updated Partnering Details | 26 | 1 |
| 62. Topamax (topiramate) Central Description Topamax | 26 | 1 |
| Last Updated 11/21/2007 63. Dapoxetine hydrochloride JANSSEN-CILAG Kidneys and Genito-Urinary System Description Dapoxetine | 26 | 1 |
| Last Updated 64. BAL5788 Description | 27 | 1 |
| Therapeutic | 27 | 1 |
| Current Trial Trial Details | 28 | 2 |
| Last Updated Partnering Details | 30 | 1 |
| 65. Velcade Description | 30 | 1 |
| Therapeutic Current Trial Trial Details | 30 | 7 |
| Last Updated Partnering Details | 34 | 1 |
| 66. BAL5788 Description | 34 | 1 |
| Last Updated 67. BAL5788 Description | 34 | 1 |
| Last Updated 68. Dacogen Description | 35 | 1 |
| Last Updated 69. Dacogen Description | 36 | 1 |
| Last Updated | 37 | 1 |
| Corporate Partners | 38 | 1 |
| Company Announcements | 39 | 1 |
| 9/18/2007 -- Janssen Pharmaceutica reorganizes its Belgian activities | 39 | 1 |
| 2/14/2005 -- Janssen-Cilag supports patient avocacy workshop | 39 | 1 |
| 2/23/2004 -- Physicians Underestimate the Impact of Cancer-related Fatigue on Patients | 39 | 1 |
| 2/10/2004 -- RISPERDAL CONSTA Significantly Reduces the need for Institutional Psychiatric Care and Related Costs | 39 | 1 |
| 2/10/2004 -- New Study demonstrates key benefits of RISPERDAL CONSTA in young adultswith Schizophrenia | 39 | 1 |
| 11/11/2003 -- Dr. Paul Janssen Passed Away | 39 | 1 |
| 5/21/2003 -- Remission Possible for many Schizophrenia Patients with help of Risperdal Consta | 40 | 1 |
| 5/19/2003 -- New Research Shows That Taking Medication Regularly Remains Major Challenge for Persons with Schizophrenia | 40 | 1 |
| 4/15/2003 -- Physicians have another Option for First-Line Treatment in Children and Adolescents with Epilepsy | 40 | 1 |
| 7/22/2002 -- Study Shows Benefits of Reminyl may be Sustained for at Least Three s for Patients with Alzheimer's Disease. | 40 | 1 |
| 4/2/2001 -- Janssen-Cilag UK Launches www.psychiatry24x7.co.uk, the First Major UK Portal in Psychiatry | 40 | 1 |
| Deals & Alliances | 41 | 1 |
| Product Update | 41 | 1 |
| 3/27/2008 -- New Studies Confirm the Benefits of Dapoxetine as a Treatment of Premature Ejaculation | 41 | 1 |
| 12/7/2007 -- Submission of Marketing Authorisation Application for Dapoxetine in Europe | 42 | 1 |
| 6/28/2007 -- Velcade (Bortezomib) for Injection Addressed Disease-Related Complications Associated with Multiple Myeloma | 42 | 1 |
| 3/30/2007 -- Study Suggests Invega Helps Patients With Schizophrenia Maintain Symptom Control | 42 | 1 |
| 12/20/2006 -- Alkermes Announces Submission of New Drug Application for Risperdal Consta in Japan | 42 | 1 |
| 4/28/2006 -- Study shows Topamax reduces number of monthly migraine days in chronic migraine patients | 43 | 1 |
| 6/14/2005 -- TMC114 Expanded Access Program for People Living with HIV/AIDS to Begin Enrollment in Autumn of 2005 | 43 | 1 |
| 6/24/2004 -- Risperdal shown to improve manic symptoms and global functioning in many patients with bipolar I Disorder | 44 | 1 |
| 6/12/2004 -- Velcade Data Confirms Long-term Survival | 44 | 1 |
| 6/11/2004 -- Preliminary Data Indicate Eprex /Erypo Improves Cognitive Function in Anaemic Cancer Patients | 44 | 1 |
| 3/5/2004 -- Topamax Proven Effective in Preventing Migraine Headaches | 44 | 1 |
| 3/1/2004 -- VELCADE (bortezomib for injection)-First new Treatment for Multiple Myeloma in a Decade-Recommended for Approval | 44 | 1 |
| 9/21/2003 -- New Data Show Risperdal (Risperidone) Produces Continuous Improvement of 'Manic' Symptoms in Bipolar Disorder | 45 | 1 |
| 9/15/2003 -- Largest Migraine Prevention Trial Programme Demonstrates Positive Effects of Topiramate | 45 | 1 |
| 9/4/2003 -- Novel Approach to Pain Relief Brings New Hope to People With Musculoskeletal Conditions | 45 | 1 |
| 9/2/2003 -- Reminyl (Galantamine) Reduces Rate of Alzheimer's Disease Progression by more Than 50 Percent Over Four s of Ther | 45 | 1 |
| 6/12/2003 -- New Treatment, Risperdal Consta, Reduces Depression and Anxiety in People with Psychotic Illness | 45 | 1 |
| 4/14/2003 -- New data Show Topamax reduces frequency of Migraine Headaches | 45 | 1 |
| 9/23/2002 -- New Study Finds Anticonvulsant Drug, Topamax, Effective in Reducing Frequency of Migraine Headaches | 45 | 1 |
| 8/26/2002 -- New Analysis Shows Risperdal Consta can reduce need for hospitalization in Persons with Schizophrenia | 46 | 1 |
| 4/10/2002 -- Data Suggest Reminyl Effectively Treats Dementia in Patients with Cerebrovascular Disease. | 46 | 1 |
| 9/4/2001 -- New Drug Application for first Injectable, Long-Acting Atypical Antipsychotic Submitted to FDA. | 46 | 1 |
| 5/10/2001 -- Reminyl is First Drug to Show Efficacy in Treatment of Dementia in Patients with Cerebrovascular Disease | 46 | 1 |
| 5/2/2001 -- Risperdal is First 'Atypical' Antipsychotic to Show Efficacy in Long-Acting Injectable Formulation | 46 | 1 |
| 11/10/2000 -- H. Pylori Eradication for Pariet (rabeprazole sodium) in Europe | 46 | 1 |
| 9/11/2000 -- Oral Formulation of Antipsychotic Offers 'User-Friendly' Alternative to Injections for | 46 | 1 |
| Patients With Acute Psychosis (Risperdal) | 47 | 1 |
| Regulatory | 47 | 1 |
| 3/18/2008 -- FDA issues Approvable Letter for ceftobiprole, a new anti-MRSA broad-spectrum antibiotic | 47 | 1 |
| 8/22/2007 -- FDA Approves Risperdal to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania | 47 | 1 |
| 7/19/2007 -- European Medicines Agency Accepts Review of Marketing Authorization Application for New Antibiotic Doripenem | 47 | 1 |
| 6/28/2007 -- Invega Receives Marketing Authorization In European Union For Treatment Of Schizophrenia | 47 | 1 |
| 4/27/2007 -- FDA Approves Invega (paliperidone) For Long-Term Maintenance Treatment Of Schizophrenia | 47 | 1 |
| 4/13/2007 -- FDA Approves New Dose of Risperdal Consta for Schizophrenia Treatment | 48 | 1 |
| 3/1/2007 -- FDA Grants Pediatric Exclusivity for Risperdal | 48 | 1 |
| 2/16/2007 -- Anti-HIV Medication Prezista Receives Conditional Marketing Authorization in the European Union | 48 | 1 |
| 12/20/2006 -- Invega (paliperidone) Approved By FDA As New Treatment For Schizophrenia | 48 | 1 |
| 8/10/2006 -- Dacogen (Decitabine) for Injection Receives U.S. Orphan Drug Designation for Patients with AML | 48 | 1 |
| 8/1/2006 -- Dacogen (decitabine) For Injection Receives European Orphan Drug Designation For Patients With AML | 48 | 1 |
| 8/9/2002 -- Risperdal Consta to be Launched in United Kingdom | 49 | 1 |
| 8/1/2002 -- Germany Approves Risperdal Consta, First Atypical Antipsychotic to be Available as Long-Acting Injection | 49 | 1 |
| 6/6/2002 -- Breakthrough in Birth Control as Contraceptive Patch Approved | 49 | 1 |
| 2/28/2001 -- Reminyl, New Treatment for Alzheimer's Disease, Receives FDA Approval | 49 | 1 |
